Notice2023-12528

Notice Pursuant to the National Cooperative Research and Production Act of 1993-Pistoia Alliance, Inc.

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
June 13, 2023

Issuing agencies

Justice DepartmentAntitrust Division

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 113 (Tuesday, June 13, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 113 (Tuesday, June 13, 2023)]
[Notices]
[Page 38539]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-12528]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Pistoia Alliance, Inc.

    Notice is hereby given that, on April 14, 2023, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (the ``Act''), Pistoia Alliance, Inc. filed 
written notifications simultaneously with the Attorney General and the 
Federal Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances. Specifically, Amgen, Thousand 
Oaks, CA; QuEra, Boston, MA; BioNTech, Mainz, Germany; Parexel, Durham, 
NC; Syngenta, Basel, Switzerland; Brandon Wall (individual), Austin, 
TX; National Cancer Center Hospital, Kashiwa, Japan; Vortex 
Biosciences, Cambridge, United Kingdom; Suzanne Studinger (individual), 
Basel, Switzerland; Rancho Biosciences, Rancho Santa Fe, CA; and 
Cepheus Consultancy Limited, Canterbury, United Kingdom have been added 
as parties to this venture.
    Also, IOS Press, Amsterdam, The Netherlands; Sanofi, Cambridge, MA; 
Atom Computing, Berkeley, CA; Uncountable, San Francisco, CA; Elemental 
Machines, Cambridge, MA; Biogen, Cambridge, MA; Consource, Tokyo, 
Japan; Dotmatics Limited, Bishop Stortford, United Kingdom; PRISM, 
Cambridge, MA; Causaly, London, United Kingdom; Scitara, Marlboro, MA; 
Intelligencia, New York, NY; Perkin Elmer, Boston, MA; and Result 
Works, Somerville, MA have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and Pistoia Alliance, Inc. intends to 
file additional written notifications disclosing all changes in 
membership.
    On May 28, 2009, Pistoia Alliance, Inc. filed its original 
notification pursuant to Section 6(a) of the Act. The Department of 
Justice published the initial notice in the Federal Register pursuant 
to Section 6(b) of the Act on July 15, 2009 (74 FR 34364).
    The last notification was filed with the Department on January 17, 
2023. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on March 27, 2023 (88 FR 18179).

Suzanne Morris,
Deputy Director, Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2023-12528 Filed 6-12-23; 8:45 am]
BILLING CODE 4410-11-P


</pre></body>
</html>
Indexed from Federal Register on June 13, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.